What are the FDG‑PET avid uptake patterns in osteoarthritis versus rheumatoid arthritis versus polymyalgia rheumatica?

FDG-PET Uptake Patterns in Osteoarthritis, Rheumatoid Arthritis, and Polymyalgia Rheumatica

Each condition demonstrates distinct FDG uptake patterns: osteoarthritis shows diffuse periarticular uptake at weight-bearing joints, rheumatoid arthritis displays symmetric small joint synovial uptake with hand/wrist involvement, and polymyalgia rheumatica exhibits characteristic bilateral uptake at ischial tuberosities, hip capsules, shoulder joints, and interspinous bursae.

Polymyalgia Rheumatica (PMR)

PMR demonstrates the most characteristic and diagnostically useful FDG-PET pattern among these three conditions 1.

Classic Uptake Pattern

• Bilateral uptake equal to or exceeding liver intensity at specific anatomical sites 2:
  • Ischial tuberosities (91% of PMR patients)
  • Shoulder joints (86%)
  • Hip joints (83%)
  • Lumbar spinal processes (70%)
  • Greater trochanters
  • Sternoclavicular joints
  • Interspinous bursae (cervical and lumbar)

Quantitative Criteria

The combination of four SUVmax values from both anterolateral hip capsules and both ischial tuberosities achieves 91.3% sensitivity and 97.6% specificity with a cut-off of 11.0 SUV in treatment-naïve PMR patients 3. This represents the most diagnostically robust quantitative approach.

Critical Caveat

Recent evidence demonstrates that whole-body and site-specific FDG uptake patterns have limited value in differentiating PMR from other inflammatory diseases 2. Many non-PMR inflammatory conditions can mimic PMR patterns. Therefore, FDG-PET/CT should primarily be used to rule out PMR rather than confirm it 2. The 2025 EANM/SNMMI guidelines recommend FDG-PET/CT in patients with known or suspected PMR to confirm or exclude co-existing giant cell arteritis 1.

Imaging Protocol Specifics

• Uptake time: minimum 60 minutes, preferably 90-120 minutes post-injection 1
• Field of view: vertex-to-knees with arms next to body 1
• Grading scale for vascular uptake (4-point visual scale):
  • Grade 0-1: negative for large vessel vasculitis
  • Grade 2: equivocal (caution with digital PET)
  • Grade 3: positive (uptake > liver) 1

Rheumatoid Arthritis (RA)

RA demonstrates a distinctly different pattern focused on synovial inflammation 4.

Characteristic Features

• Symmetric polyarticular synovial uptake with predilection for:
  • Small joints of hands and wrists
  • Metacarpophalangeal and proximal interphalangeal joints
  • Metatarsophalangeal joints
  • Larger joints (knees, shoulders) in established disease

Distinguishing from PMR

RA can be significantly differentiated from PMR at initial diagnosis using the same anatomical regions assessed in PMR (hip capsules, ischial tuberosities), with RA showing lower uptake in these extra-articular sites 3. The key differentiator is that RA predominantly affects synovial joints themselves rather than periarticular structures and bursae.

Clinical Utility

FDG-PET/CT in RA is useful for:

• Evaluating synovial metabolic activity (visual and SUV measurement) 4
• Response assessment to therapy 4
• Detecting vasculitis complications 4
• Excluding underlying malignancy when disease course is atypical 4

Emerging Applications

18F-sodium fluoride (NaF) PET/CT can assess synovial osteoblastic activity in RA, complementing FDG findings 4, 5.

Osteoarthritis (OA)

OA shows the least specific but most anatomically predictable pattern 6.

Uptake Characteristics

Diffuse periarticular FDG uptake is the hallmark pattern associated with clinical findings of osteoarthritis 6. This differs fundamentally from the focal patterns seen in acute injury or the symmetric small joint patterns of RA.

Anatomical Distribution

• Weight-bearing joints (hips, knees)
• Shoulders (when symptomatic)
• Pattern: diffuse rather than focal
• Intensity correlates positively with patient age 6

Diagnostic Limitations

• SUV values show positive correlation with age but no reliable association with specific clinical findings 6
• Focal uptake patterns (e.g., focal greater tuberosity uptake suggesting rotator cuff injury, focal glenoid uptake in frozen shoulder) are less reliably related to OA 6
• Background physiologic uptake in normal joints increases with age, reducing specificity 6

Practical Differentiation Algorithm

When interpreting FDG-PET in suspected inflammatory arthropathy:

1. Assess distribution pattern first:

   • Bilateral periarticular/bursal (ischial tuberosities, hip capsules, interspinous bursae) → Consider PMR
   • Symmetric small joint synovial → Consider RA
   • Diffuse large joint periarticular → Consider OA

2. Evaluate intensity and quantification:

   • SUVmax >11.0 at hip capsules + ischial tuberosities → PMR likely 3
   • Moderate uptake at multiple small joints → RA pattern
   • Age-related diffuse uptake → OA likely 6

3. Check for distinguishing features:

   • Large vessel uptake (aorta Grade 3) → PMR with giant cell arteritis 1
   • Hand/wrist predominance → RA
   • Isolated large joint involvement → OA

4. Integrate clinical context:

   • PMR: age >50, elevated inflammatory markers, proximal pain/stiffness
   • RA: symmetric small joint involvement, positive serology
   • OA: mechanical pain, age-related, no systemic inflammation

Important Pitfalls

• Do not rely solely on FDG-PET patterns to diagnose PMR, as other inflammatory conditions can mimic the pattern 2
• Timing matters: Imaging should occur within 40 minutes of FDG injection for optimal results 7, though PMR/vasculitis protocols recommend 60-90 minutes 1
• Glucocorticoid effect: Even short courses (<3 days) of high-dose IV glucocorticoids may affect uptake in PMR/giant cell arteritis 1
• Digital PET systems show higher sensitivity for cranial artery involvement but may show Grade 2 aortic uptake in normal patients 1
• Specificity limitations: FDG uptake reflects glucose metabolism in inflammatory cells, which is "inconsistent and may be increased, normal or decreased" 7